168 related articles for article (PubMed ID: 12093285)
1. DNA sequence recognition by the antitumor drug ditercalinium.
Crow SD; Bailly C; Garbay-Jaureguiberry C; Roques B; Shaw BR; Waring MJ
Biochemistry; 2002 Jul; 41(27):8672-82. PubMed ID: 12093285
[TBL] [Abstract][Full Text] [Related]
2. Sequence-selective intercalation of antitumour bis-naphthalimides into DNA. Evidence for an approach via the major groove.
Bailly C; Braña M; Waring MJ
Eur J Biochem; 1996 Aug; 240(1):195-208. PubMed ID: 8797854
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; Braña MF; Bailly C
Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
[TBL] [Abstract][Full Text] [Related]
4. 1H- and 31P-NMR studies of ditercalinium binding to a d(GCGC)2 and d(CCTATAGG)2 minihelices: a sequence specificity study.
Delepierre M; Milhe C; Namane A; Dinh TH; Roques BP
Biopolymers; 1991 Feb; 31(3):331-53. PubMed ID: 1868161
[TBL] [Abstract][Full Text] [Related]
5. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
6. DNA distortion in bis-intercalated complexes.
Peek ME; Lipscomb LA; Bertrand JA; Gao Q; Roques BP; Garbay-Jaureguiberry C; Williams LD
Biochemistry; 1994 Apr; 33(13):3794-800. PubMed ID: 8142381
[TBL] [Abstract][Full Text] [Related]
7. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
[TBL] [Abstract][Full Text] [Related]
8. Recognition of ATGA sequences by the unfused aromatic dication DB293 forming stacked dimers in the DNA minor groove.
Bailly C; Tardy C; Wang L; Armitage B; Hopkins K; Kumar A; Schuster GB; Boykin DW; Wilson WD
Biochemistry; 2001 Aug; 40(33):9770-9. PubMed ID: 11502170
[TBL] [Abstract][Full Text] [Related]
9. The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli.
Lambert B; Jones BK; Roques BP; Le Pecq JB; Yeung AT
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6557-61. PubMed ID: 2671994
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced DNA repair: X-ray structure of a DNA-ditercalinium complex.
Gao Q; Williams LD; Egli M; Rabinovich D; Chen SL; Quigley GJ; Rich A
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2422-6. PubMed ID: 2006181
[TBL] [Abstract][Full Text] [Related]
11. Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA.
Bailly C; Suh D; Waring MJ; Chaires JB
Biochemistry; 1998 Jan; 37(4):1033-45. PubMed ID: 9454594
[TBL] [Abstract][Full Text] [Related]
12. DNA-ditercalinium interactions: implications for recognition of damaged DNA.
Williams LD; Gao Q
Biochemistry; 1992 May; 31(17):4315-24. PubMed ID: 1567878
[TBL] [Abstract][Full Text] [Related]
13. Tight binding of the antitumor drug ditercalinium to quadruplex DNA.
Carrasco C; Rosu F; Gabelica V; Houssier C; De Pauw E; Garbay-Jaureguiberry C; Roques B; Wilson WD; Chaires JB; Waring MJ; Bailly C
Chembiochem; 2002 Dec; 3(12):1235-41. PubMed ID: 12465032
[TBL] [Abstract][Full Text] [Related]
14. Targeting DNA with novel diphenylcarbazoles.
Dias N; Jacquemard U; Baldeyrou B; Tardy C; Lansiaux A; Colson P; Tanious F; Wilson WD; Routier S; Mérour JY; Bailly C
Biochemistry; 2004 Dec; 43(48):15169-78. PubMed ID: 15568808
[TBL] [Abstract][Full Text] [Related]
15. Sequence specificity of the binding of 9-aminoacridine- and amsacrine-4-carboxamides to DNA studied by DNase I footprinting.
Bailly C; Denny WA; Mellor LE; Wakelin LP; Waring MJ
Biochemistry; 1992 Apr; 31(13):3514-24. PubMed ID: 1554731
[TBL] [Abstract][Full Text] [Related]
16. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
[TBL] [Abstract][Full Text] [Related]
17. Drug-DNA sequence-dependent interactions analysed by electric linear dichroism.
Bailly C; Hénichart JP; Colson P; Houssier C
J Mol Recognit; 1992 Dec; 5(4):155-71. PubMed ID: 1339484
[TBL] [Abstract][Full Text] [Related]
18. Recognition elements that determine affinity and sequence-specific binding to DNA of 2QN, a biosynthetic bis-quinoline analogue of echinomycin.
Bailly C; Echepare S; Gago F; Waring MJ
Anticancer Drug Des; 1999 Jun; 14(3):291-303. PubMed ID: 10500504
[TBL] [Abstract][Full Text] [Related]
19. DNase I susceptibility of bent DNA and its alteration by ditercalinium and distamycin.
Mendoza R; Markovits J; Jaffrezou JP; Muzard G; Le Pecq JB
Biochemistry; 1990 May; 29(21):5035-43. PubMed ID: 2198937
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
